$FZMD
Fuse Medical, Inc.

2016 Q4 Form 10-K Financial Statement

#000156459018007778 Filed on April 06, 2018

View on sec.gov

Income Statement

Concept 2016 Q4 2016 2015 Q4
Revenue $25.25M $567.6K $480.0K
YoY Change 5160.42% -66.15% 54.84%
Cost Of Revenue $11.11M $204.0K $230.0K
YoY Change 4730.43% -69.28% -8.0%
Gross Profit $14.13M $363.6K $260.0K
YoY Change 5334.62% -64.09% 333.33%
Gross Profit Margin 55.96% 64.05% 54.17%
Selling, General & Admin $10.64M $4.171M $240.0K
YoY Change 4333.33% 131.15% -40.0%
% of Gross Profit 75.3% 1147.21% 92.31%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $10.00K $19.09K $10.00K
YoY Change 0.0% -23.86%
% of Gross Profit 0.07% 5.25% 3.85%
Operating Expenses $10.65M $11.25M $240.0K
YoY Change 4337.5% 522.45% -40.0%
Operating Profit $3.480M $3.163M $20.00K
YoY Change 17300.0% -498.2% -105.88%
Interest Expense -$110.0K $146.9K $0.00
YoY Change 2088.93% -100.0%
% of Operating Profit -3.16% 4.64% 0.0%
Other Income/Expense, Net -$146.9K
YoY Change 1965.82%
Pretax Income $3.340M $3.016M $10.00K
YoY Change 33300.0% -476.33% -102.86%
Income Tax $51.63K $0.00
% Of Pretax Income 1.71% 0.0%
Net Earnings $3.340M $3.016M $10.00K
YoY Change 33300.0% -476.33% -102.86%
Net Earnings / Revenue 13.23% 531.44% 2.08%
Basic Earnings Per Share $0.42
Diluted Earnings Per Share $206.3K $0.33 $1.449K
COMMON SHARES
Basic Shares Outstanding 7.186M
Diluted Shares Outstanding 9.215M

Balance Sheet

Concept 2016 Q4 2016 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $780.0K $778.5K $10.00K
YoY Change 7700.0% 9439.83% -85.71%
Cash & Equivalents $778.4K $778.5K $8.157K
Short-Term Investments
Other Short-Term Assets $20.00K $23.02K $20.00K
YoY Change 0.0% 22.25% -60.0%
Inventory $25.33K $11.43M $81.21K
Prepaid Expenses
Receivables $58.07K $6.508M $298.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $754.4K $18.74M $406.2K
YoY Change 85.72% 4512.54% -17.1%
LONG-TERM ASSETS
Property, Plant & Equipment $8.931K $14.75K $24.98K
YoY Change -64.24% -40.95% -50.04%
Goodwill $820.0K
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $3.820K $0.00
YoY Change 0.0%
Other Assets
YoY Change
Total Long-Term Assets $18.82M $839.2K $28.80K
YoY Change 65252.1% 2813.96% -52.0%
TOTAL ASSETS
Total Short-Term Assets $754.4K $18.74M $406.2K
Total Long-Term Assets $18.82M $839.2K $28.80K
Total Assets $19.58M $19.58M $435.0K
YoY Change 4400.13% 4400.08% -20.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.453M $2.453M $247.2K
YoY Change 892.37% 671.89% -22.76%
Accrued Expenses $5.097K $3.068M $12.27K
YoY Change -58.45% 24904.48% 22.67%
Deferred Revenue
YoY Change
Short-Term Debt $3.460M $3.455M $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.976M $8.976M $330.0K
YoY Change 2619.7% 2619.68% -5.7%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $100.0K
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $100.0K
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.976M $8.976M $330.0K
Total Long-Term Liabilities $0.00 $0.00 $100.0K
Total Liabilities $316.5K $8.976M $430.0K
YoY Change -26.4% 1987.27% 22.87%
SHAREHOLDERS EQUITY
Retained Earnings -$2.901M -$2.315M
YoY Change 25.31%
Common Stock $3.352M $2.320M
YoY Change 44.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.60M $10.60M $7.998M
YoY Change
Total Liabilities & Shareholders Equity $767.1K $19.58M $435.0K
YoY Change 76.35% 4400.08% -20.91%

Cashflow Statement

Concept 2016 Q4 2016 2015 Q4
OPERATING ACTIVITIES
Net Income $3.340M $3.016M $10.00K
YoY Change 33300.0% -476.33% -102.86%
Depreciation, Depletion And Amortization $10.00K $19.09K $10.00K
YoY Change 0.0% -23.86%
Cash From Operating Activities $2.840M $2.790M -$50.00K
YoY Change -5780.0% -843.81% -83.87%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 -$10.00K
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $660.0K $655.4K $0.00
YoY Change 50314.62%
Cash From Investing Activities $660.0K $655.4K -$10.00K
YoY Change -6700.0% -9449.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.030M -2.931M 0.000
YoY Change -1008.11% -100.0%
NET CHANGE
Cash From Operating Activities 2.840M 2.790M -50.00K
Cash From Investing Activities 660.0K 655.4K -10.00K
Cash From Financing Activities -3.030M -2.931M 0.000
Net Change In Cash 470.0K 514.8K -60.00K
YoY Change -883.33% -966.7% -86.96%
FREE CASH FLOW
Cash From Operating Activities $2.840M $2.790M -$50.00K
Capital Expenditures $0.00 $0.00 -$10.00K
Free Cash Flow $2.840M $2.790M -$40.00K
YoY Change -7200.0% -827.7% -87.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 us-gaap Assets
Assets
19575798
CY2016Q4 us-gaap Goodwill
Goodwill
820650
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2452922
CY2016Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
150000
CY2016Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
3305347
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8976323
CY2017Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
375278
CY2016 fzmd Commissions
Commissions
7056430
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4170835
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
85838
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10065
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
71091
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
514822
CY2016 fzmd Member Contributions Of Inventory
MemberContributionsOfInventory
375739
CY2017 fzmd Member Distributions Of Inventory
MemberDistributionsOfInventory
242912
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-146921
CY2016 us-gaap Operating Expenses
OperatingExpenses
11246356
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
3163407
CY2016 us-gaap Interest Expense
InterestExpense
146921
CY2017Q4 fzmd Allowance For Inventories Current
AllowanceForInventoriesCurrent
1110742
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5356475
CY2017 fzmd Commissions
Commissions
5641122
CY2017 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
5367
CY2016 us-gaap Depreciation
Depreciation
19091
CY2017 us-gaap Interest Expense
InterestExpense
161669
CY2017 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
43308
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-118361
CY2017 us-gaap Net Income Loss
NetIncomeLoss
699678
CY2016 us-gaap Net Income Loss
NetIncomeLoss
3016486
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16027794
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7185890
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19473553
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9214606
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
7998142
CY2016 fzmd Adjustments To Additional Paid In Capital Member Contribution
AdjustmentsToAdditionalPaidInCapitalMemberContribution
775949
CY2016 fzmd Adjustments To Additional Paid In Capital Member Distribution
AdjustmentsToAdditionalPaidInCapitalMemberDistribution
2481178
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1290076
CY2017 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
42609
CY2017 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
-19244543
CY2017 fzmd Adjustments To Additional Paid In Capital Deferred Tax Asset
AdjustmentsToAdditionalPaidInCapitalDeferredTaxAsset
375278
CY2017 fzmd Adjustments To Additional Paid In Capital Member Contribution
AdjustmentsToAdditionalPaidInCapitalMemberContribution
1738620
CY2017 fzmd Adjustments To Additional Paid In Capital Member Distribution
AdjustmentsToAdditionalPaidInCapitalMemberDistribution
2192626
CY2016 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
13094
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
42609
CY2017 fzmd Gain Loss On Disposal Of Property And Equipment
GainLossOnDisposalOfPropertyAndEquipment
5067
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
62096
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-995785
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2022723
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
139993
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9448
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-107
CY2017 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
3822
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
178477
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1313409
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1236527
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
199177
CY2017 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
848
CY2017 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1604536
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2790338
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20334
CY2017 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
8732
CY2016 fzmd Proceeds From Reverse Acquisition
ProceedsFromReverseAcquisition
655390
CY2017 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-11602
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
655390
CY2017 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
15580346
CY2016 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
14118720
CY2017 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
15690350
CY2016 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
13208210
CY2017 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
273044
CY2016 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
375210
CY2016 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
2395606
CY2017 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1566666
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-2930906
CY2017 us-gaap Interest Paid
InterestPaid
139507
CY2016 us-gaap Interest Paid
InterestPaid
150762
CY2016 fzmd Member Contributions Through Reduction Of Accounts Payable
MemberContributionsThroughReductionOfAccountsPayable
25000
CY2016 fzmd Member Distributions Of Inventory
MemberDistributionsOfInventory
85572
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the consolidated financial statements in accordance with generally accepted accounting principles in the United State, (&#8220;GAAP&#8221;). GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements.&nbsp;&nbsp;Actual results could differ from those estimates.&nbsp;&nbsp;Significant estimates in the accompanying consolidated financial statements include the allowances for doubtful accounts and contractual pricing, valuation of inventories, accrued commissions, the fair value calculation of stock based compensation, and fair value of Earn-Out liability.</p></div>
CY2016Q4 fzmd Share Issuance Costs
ShareIssuanceCosts
64609
CY2016Q4 fzmd Proceeds From Issuance Of Common Stock Net Of Offering Costs
ProceedsFromIssuanceOfCommonStockNetOfOfferingCosts
655391
CY2017 fzmd Outstanding Common Stock Equivalents Included With Diluted Net Earnings Per Share
OutstandingCommonStockEquivalentsIncludedWithDilutedNetEarningsPerShare
700000
CY2017 fzmd Options To Purchase Included In Common Stock Equivalents
OptionsToPurchaseIncludedInCommonStockEquivalents
1302052
CY2016 fzmd Options To Purchase Included In Common Stock Equivalents
OptionsToPurchaseIncludedInCommonStockEquivalents
1304788
CY2017Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2016Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2017Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2017Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
537388
CY2016Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
421636
CY2017 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2016 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2017Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2017Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
0
CY2017 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2016Q4 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
64609
CY2017 fzmd Percentage Of Common Stock Issued
PercentageOfCommonStockIssued
0.614
CY2017 fzmd Percentage Of Common Stock Outstanding
PercentageOfCommonStockOutstanding
0.614
CY2016Q4 us-gaap Goodwill
Goodwill
820000
CY2016 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
26111382
CY2016 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
2449361
CY2016 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.34
CY2017 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
26960
CY2017 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
607
CY2017 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
300
CY2017 fzmd Retirement Of Fixed Assets No Use With Net Book Value
RetirementOfFixedAssetsNoUseWithNetBookValue
3058
us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
117500
CY2017Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
150000
CY2016Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
150000
CY2017Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
150000
CY2016Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
150000
CY2017 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
27000
CY2016 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
13587
CY2016 fzmd Amortization Of The Beneficial Conversion Feature
AmortizationOfTheBeneficialConversionFeature
13094
CY2017 us-gaap Loss Contingency Lawsuit Filing Date
LossContingencyLawsuitFilingDate
January 27, 2014
CY2017 us-gaap Loss Contingency Name Of Plaintiff
LossContingencyNameOfPlaintiff
M. Richard Cutler and Cutler Law Group, P.C.
CY2017 us-gaap Loss Contingency Name Of Defendant
LossContingencyNameOfDefendant
Fuse, Alan Meeker, Rusty Shelton, Jonathan Brown, Robert H. Donehew and Golf Rounds.com, Inc.
CY2017 us-gaap Loss Contingency Date Of Dismissal
LossContingencyDateOfDismissal
2014-04-21
CY2017 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
46465
CY2017 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2017-12-31
CY2017 fzmd Operating Lease Requires Monthly Payments
OperatingLeaseRequiresMonthlyPayments
14000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
9000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
5000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
3000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
500
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
17500
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y6M
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.00
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.62
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.00
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
1.62
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0143
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1304788
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2736
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1302052
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1302052
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.22
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
12.13
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.20
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.20
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y3M18D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y3M18D
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1717000
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1717000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.09
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
40818
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
51627
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
40818
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
51627
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
40818
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
51627
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
172704
CY2017Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
40342
CY2017Q4 fzmd Deferred Tax Assets Accounts Receivable
DeferredTaxAssetsAccountsReceivable
81927
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
57458
CY2017Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
25792
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
378223
CY2017Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
0
CY2017Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2945
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2945
CY2017Q4 fzmd Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
375278
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
308026
CY2017 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-308026
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
375278
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
224381
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
80850
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
305231
CY2016Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
0
CY2016Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
2795
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.058
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.017
CY2017 fzmd Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
0.038
CY2016Q4 fzmd Deferred Tax Assets Liabilities
DeferredTaxAssetsLiabilities
2795
CY2016Q4 fzmd Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
308026
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
700713
CY2016 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-392687
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
822399
CY2017 fzmd Net Operating Loss Carryforwards Earliest Expiration Year
NetOperatingLossCarryforwardsEarliestExpirationYear
2018
CY2017 fzmd Net Operating Loss Carryforwards Latest Expiration Year
NetOperatingLossCarryforwardsLatestExpirationYear
2037
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2016 fzmd Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
0.003
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.205
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.198
CY2017 fzmd Effective Income Tax Rate Reconciliation Flow Through Structure
EffectiveIncomeTaxRateReconciliationFlowThroughStructure
-0.593
CY2016 fzmd Effective Income Tax Rate Reconciliation Flow Through Structure
EffectiveIncomeTaxRateReconciliationFlowThroughStructure
-0.421
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.000
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.130
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.058
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.017
CY2017 fzmd Number Of Primary Stockholders
NumberOfPrimaryStockholders
2
CY2017 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
1055000
CY2016 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
396000
CY2017 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
128000
CY2016 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
8000

Files In Submission

Name View Source Status
0001564590-18-007778-index-headers.html Edgar Link pending
0001564590-18-007778-index.html Edgar Link pending
0001564590-18-007778.txt Edgar Link pending
0001564590-18-007778-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
fzmd-10k_20171231.htm Edgar Link pending
fzmd-20171231.xml Edgar Link completed
fzmd-20171231.xsd Edgar Link pending
fzmd-20171231_cal.xml Edgar Link unprocessable
fzmd-20171231_def.xml Edgar Link unprocessable
fzmd-20171231_lab.xml Edgar Link unprocessable
fzmd-20171231_pre.xml Edgar Link unprocessable
fzmd-ex1010_558.htm Edgar Link pending
fzmd-ex1011_560.htm Edgar Link pending
fzmd-ex1012_559.htm Edgar Link pending
fzmd-ex1013_520.htm Edgar Link pending
fzmd-ex1014_524.htm Edgar Link pending
fzmd-ex1019_564.htm Edgar Link pending
fzmd-ex104_562.htm Edgar Link pending
fzmd-ex105_557.htm Edgar Link pending
fzmd-ex106_563.htm Edgar Link pending
fzmd-ex107_556.htm Edgar Link pending
fzmd-ex108_561.htm Edgar Link pending
fzmd-ex109_555.htm Edgar Link pending
fzmd-ex211_525.htm Edgar Link pending
fzmd-ex311_6.htm Edgar Link pending
fzmd-ex312_11.htm Edgar Link pending
fzmd-ex321_12.htm Edgar Link pending
fzmd-ex41_523.htm Edgar Link pending
g201804061235453515360.jpg Edgar Link pending
g201804061235453675360.jpg Edgar Link pending
g201804061235453695360.jpg Edgar Link pending
g201804061235453745360.jpg Edgar Link pending
g201804061235453835360.jpg Edgar Link pending
g201804061235473906095.jpg Edgar Link pending
g201804061236338774933.jpg Edgar Link pending
g201804061236338794935.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending